drugset / Trial / NCT04714177
Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage
Phase 2
Unknown
390 enrolled
First Affiliated Hospital, Sun Yat-Sen University
Jiangsu Simcere Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
pending
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-03-01
- Completion
- 2023-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edaravone Dexborneol | Unknown | 37.5 mg | — |